Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT06482944 · Vanderbilt University

Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes

What this study is about

This study will address the following aims: Aim 1 (primary): Conduct a pilot RCT to evaluate the feasibility, acceptability, enrollment, and retention rates of adult-child pairs after a 12-week family-centered, non-calorie restricted whole foods diet. Feasibility: ≥80% participant retention and completion of study outcome measures.

View original scientific description

This study will address the following aims: Aim 1 (primary): Conduct a pilot RCT to evaluate the feasibility, acceptability, enrollment, and retention rates of adult-child pairs after a 12-week family-centered, non-calorie restricted whole foods diet. Feasibility: ≥80% participant retention and completion of study outcome measures. Acceptability: ≥75 adult diet satisfaction via survey report and/or perceived diet satisfaction via focus groups. Aim 2: Conduct a pilot RCT to evaluate the preliminary effectiveness of a non-calorie restricted whole foods diet on adult HbA1c at 12 weeks and adult/child diet quality during the 12-week intervention. Aim 2a: Evaluate intervention effects on HbA1c measures in adults with prediabetes. Hypothesis 2a: Adults randomized to the treatment group will have lower HbA1c measures at 12 weeks than those in the control group. Aim 2b: Evaluate intervention effects on the diet quality (via the 2020 HEI) of adults and children. Hypothesis 2b: Adults and children randomized to the treatment group will have a higher diet quality score during the 12-week intervention period compared to adults and children in the control group. Aim 3: Conduct family focus groups to understand how SDOH and individual/family needs and preferences may be perceived barriers or facilitators of diet adherence.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • For this study, eligible adults will be those that:
  • are 25 to 59 years of age at time of initial screen and identify as a parent to at least one child or adolescent 6-18 years;
  • have a body mass index of between ≥23kg/m2 to \<40kg/m2;
  • have prediabetes (based on American Diabetes Association criteria of either fasting plasma glucose of ≥100 mg/dL, HgbA1c 5.7-6.4%, or 2-hour plasma glucose during 75-g oral glucose tolerance test \[OGTT\] 140 mg/dL to 199 mg/dL) with recent lab values reported within the prior 6-12 months and confirmed by an HbA1c A1cNow+ collected prior to enrollment (\*see comment below);
  • have no special dietary restrictions or food allergies that would prohibit consumption of a variety of foods/beverages;
  • are English speaking;
  • reside in Greater Nashville Tennessee and willing to come to Vanderbilt campus and Vanderbilt University Medical Center for required study visits;
  • are without medical conditions that would limit participation in a diet-related study (e.g., tube feeding, dysphagia, severe food allergy causing anaphylaxis);
  • are able to participate in a 12-week dietary program that requires home preparation/cooking for meals and snacks; For this study, eligible offspring will be those that:
  • Are 6-18 years at time of initial screen;
  • Have an index parent with prediabetes that is actively enrolled in the program;
  • have body mass index ≥5th percentile for age and gender on standardized CDC growth curves;
  • have no special dietary restrictions or food allergies that would prohibit consumption of a variety of foods/beverages;
  • have parental commitment to participate in a 12-week research study
  • are English speaking;
  • reside in the Greater Nashville Tennessee area and live at home with their index parent during the duration of 12- week study;
  • are without medical conditions that would limit participation in a diet-related study (e.g., tube feeding, dysphagia, severe food allergy causing anaphylaxis);
  • are able to participate in a 12-week dietary program that includes at least dinner and snacks provided during after-school hours;

Exclusion criteria

  • Adult exclusion criteria include:
  • Adults who's HbA1c test is outside of the HbA1c range during screening\
  • (see details related to screening results)
  • adults outside the specified age range of \<25 years or \>59 years;
  • adults whose body mass index is \<23kg/m2 or those with a body mass index ≥40kg/m2 as that degree of morbid obesity represents a different phenotype where dietary behavioral intervention alone may not be sufficient to achieve weight loss);
  • receiving care by a healthcare provider (i.e., MD, NP, PA) for a complicated diagnosis of prediabetes that requires routine glycemic monitoring or frequent healthcare visits for management/treatment;
  • adults actively participating in any type of weight loss program (dietary or physical activity)
  • adults with a prior history of type 2 diabetes;
  • adults who are not English speaking or have limited English-language proficiency;
  • adults with special dietary restrictions, food allergies, or medical conditions that prohibit participation in a diet-related study;
  • adults with serious mental or neurologic illness that impairs the ability to consent/participate;
  • women who are pregnant or nursing due to increased metabolic state requiring greater energy requirements;
  • adults currently taking medications to treat diabetes or to promote weight loss;
  • adults living outside Greater Nashville Tennessee or who are unwilling to travel to Vanderbilt for study visits;
  • adults who do not otherwise meet the eligibility criteria listed in sections above as determined by pre-screen; Offspring (child\[ren\] and adolescent\[s\]) exclusion criteria include:
  • children/adolescents outside the specified age range of \<6 years or \>18 years;
  • children/adolescents whose body mass index is \<5th percentile for age and gender on standardized CDC growth curves;
  • children/adolescents who do not have an eligible index parent participating in the study;
  • children who do not have parental commitment to participate consistently for 12-weeks
  • children/adolescents who are not English speaking or have limited English-language proficiency;
  • children/adolescents with special dietary restrictions, food allergies, or medical conditions that prohibit participation in a diet-related study;
  • children/adolescents who display dissenting behaviors during baseline data collection;
  • children/adolescents actively participating in any type of weight loss program (medical or lifestyle);
  • children/adolescents who do not otherwise meet the eligibility criteria listed in sections above as determined by pre-screen;

Where

  • Nashville, Tennessee

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Mar 6, 2026 · Source of record for eligibility and locations

📊
1 of 30 participants interested
3% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Nashville

Tennessee

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Essential Tremor Trials by City

Browse all essential tremor clinical trials in these cities — not just this study.

Looking for PreDiabetes Treatment in Nashville?

Join others in Tennessee exploring innovative treatment options through clinical research

PreDiabetes Treatment Options in Nashville, Tennessee

If you're searching for PreDiabetes treatment in Nashville, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Nashville and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with PreDiabetes. All study-related care is provided at no cost to participants.

Local Sites
1 locations in Tennessee
Now Enrolling
Up to 30 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for PreDiabetes?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for PreDiabetes

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This PreDiabetes Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06482944. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.